|
|
Volumn 337, Issue , 2008, Pages
|
|
Watchdog set to reject four drugs for kidney cancer on the NHS.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
BEVACIZUMAB;
DRUG DERIVATIVE;
INDOLE DERIVATIVE;
MONOCLONAL ANTIBODY;
PYRIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
RAPAMYCIN;
SORAFENIB;
SUNITINIB;
TEMSIROLIMUS;
DRUG APPROVAL;
DRUG COST;
ECONOMICS;
HUMAN;
KIDNEY TUMOR;
NATIONAL HEALTH SERVICE;
NOTE;
UNITED KINGDOM;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
DRUG APPROVAL;
DRUG COSTS;
GREAT BRITAIN;
HUMANS;
INDOLES;
KIDNEY NEOPLASMS;
PYRIDINES;
PYRROLES;
SIROLIMUS;
STATE MEDICINE;
|
|
EID: 50049133589
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.a1262 Document Type: Note |
|
Times cited : (14)
|
|
References (0)
|
